The COVID-19 pandemic has heightened consumer awareness of pathogens and greatly increased demand for products which stop the spread of disease. One newly public company presenting an opportunity in this product space is FendX Technologies (Ticker: FNDX.c). FNDX specializes in developing coating products that decrease pathogen transmission.
FNDX is 18.8% up since its IPO last Monday.
FNDX's primary product, RepelWrap, is a groundbreaking, patent-pending coating that repels viruses and bacteria upon contact. Next year FNDX plans to commercialize and release a versatile RepelWrap film product which can be adhered to surfaces to make them pathogen-repellant. This product is expected to be highly useful in healthcare settings and other highly-trafficked areas.
The company has more RepelWrap products in its development pipeline, including catheter coatings and additional formulations which it plans to release after RepelWrap film.
The surface coating market is predicted to increase at an 18% CAGR to reach US$3.5 billion by 2025. FNDX is strategically positioning itself to seize a significant portion of this market.
For more information on FendX Technologies, please visit their website at https://fendxtech.com/. Posted on behalf of FendX Technologies Inc.